Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies

BACKGROUND: Claudin-low breast carcinoma represents 19% of all breast cancer cases and is characterized by an aggressive progression with metastatic nature and high rates of relapse. Due to a lack of known specific molecular biomarkers for this breast cancer subtype, there are no targeted therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Nobrega, Franklin L., Ferreira, Débora, Martins, Ivone M., Suarez-Diez, Maria, Azeredo, Joana, Kluskens, Leon D., Rodrigues, Lígia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109716/
https://www.ncbi.nlm.nih.gov/pubmed/27842517
http://dx.doi.org/10.1186/s12885-016-2937-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109716/
https://www.ncbi.nlm.nih.gov/pubmed/27842517
http://dx.doi.org/10.1186/s12885-016-2937-2

Ejemplares similares